CA2245920A1 - Contraceptive release systems with antibacterial and/or antiviral effect - Google Patents

Contraceptive release systems with antibacterial and/or antiviral effect Download PDF

Info

Publication number
CA2245920A1
CA2245920A1 CA002245920A CA2245920A CA2245920A1 CA 2245920 A1 CA2245920 A1 CA 2245920A1 CA 002245920 A CA002245920 A CA 002245920A CA 2245920 A CA2245920 A CA 2245920A CA 2245920 A1 CA2245920 A1 CA 2245920A1
Authority
CA
Canada
Prior art keywords
beta
alpha
compound
action
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002245920A
Other languages
English (en)
French (fr)
Inventor
Klaus Stockemann
Arwed Cleve
Karin Hoffmann
Ulrich Koch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2245920A1 publication Critical patent/CA2245920A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002245920A 1996-02-12 1997-02-11 Contraceptive release systems with antibacterial and/or antiviral effect Abandoned CA2245920A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19606355.8 1996-02-12
DE19606355A DE19606355A1 (de) 1996-02-12 1996-02-12 Kontrazeptive Freisetzungssysteme mit antiviraler und/oder antibakterieller Wirkung

Publications (1)

Publication Number Publication Date
CA2245920A1 true CA2245920A1 (en) 1997-08-14

Family

ID=7785948

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002245920A Abandoned CA2245920A1 (en) 1996-02-12 1997-02-11 Contraceptive release systems with antibacterial and/or antiviral effect

Country Status (21)

Country Link
EP (1) EP0880364A2 (hu)
JP (1) JP2000506515A (hu)
KR (1) KR19990082434A (hu)
CN (1) CN1211193A (hu)
AP (1) AP9801306A0 (hu)
AU (1) AU2379297A (hu)
BG (1) BG102682A (hu)
BR (1) BR9707416A (hu)
CA (1) CA2245920A1 (hu)
CZ (1) CZ253298A3 (hu)
DE (1) DE19606355A1 (hu)
EA (1) EA199800714A1 (hu)
EE (1) EE9800239A (hu)
HU (1) HUP9901977A3 (hu)
IL (1) IL125481A0 (hu)
IS (1) IS4802A (hu)
NO (1) NO983672L (hu)
PL (1) PL328333A1 (hu)
SK (1) SK107098A3 (hu)
TR (1) TR199801551T2 (hu)
WO (1) WO1997028826A2 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1119361A4 (en) * 1998-09-10 2006-10-04 Magainin Pharma TREATMENT OF CARCINOMA WITH SQUALAMINE IN COMBINATION WITH OTHER ANTI-TUMOR AGENTS
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
WO2003082336A1 (en) * 2002-04-03 2003-10-09 Jencap Research Ltd. Female birth control method
BRPI0612309B8 (pt) * 2005-06-24 2021-05-25 Biotron Ltd compostos e composições farmacêuticas antivirais
DE102008006416A1 (de) * 2008-01-28 2009-07-30 Mayer, Thomas, Dr. med. Clindamycin zur Verwendung bei der Behandlung oder Vorbeugung der bakteriellen Vaginosis
WO2010033188A2 (en) * 2008-09-16 2010-03-25 Playtex Products, Llc. Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administering same
FI20095563A (fi) * 2009-05-20 2010-11-21 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
GB201203768D0 (en) * 2012-03-05 2012-04-18 John Richard W Medical device
DK2982352T3 (en) * 2014-06-28 2018-11-26 Laboratorios Andromaco S A CERVICALLY PESSAR CONTAINING PROGESTERON FOR EXTENDED, LONG AND CONTINUOUS RELEASE USED TO PREVENT EARLY BIRTHS
CN105796572A (zh) * 2014-08-25 2016-07-27 郭曙平 一种避孕药物及其制备方法
CN109248140A (zh) * 2017-07-14 2019-01-22 国家卫生计生委科学技术研究所 ***抗菌***环的制备方法和应用
EP3446664A1 (en) 2017-08-21 2019-02-27 Karl-Heinz Kurz Intrauterine device

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3656483A (en) * 1970-01-15 1972-04-18 Biolog Concepts Inc Intrauterine medicator
US4180064A (en) * 1972-12-27 1979-12-25 Alza Corporation System for delivering agent to environment of use over prolonged time
FR2250520B1 (hu) * 1973-11-09 1977-04-15 Cournut Rene
US4034749A (en) * 1973-12-06 1977-07-12 Schering Aktiengesellschaft Intrauterine contraceptive device
US4393871A (en) * 1977-06-27 1983-07-19 Vli Corporation Vaginal device
GB2026320A (en) * 1978-07-25 1980-02-06 Gutnick Morton Devices for the prevention of venereal disease
US4578076A (en) * 1984-03-20 1986-03-25 The Population Council, Inc. Medicated intracervical and intrauterine devices
US5229423A (en) * 1992-03-06 1993-07-20 Albert Einstein College Of Medicine Of Yeshiva University Use of butylurea as a contraceptive agent

Also Published As

Publication number Publication date
HUP9901977A3 (en) 2000-06-28
HUP9901977A2 (hu) 1999-10-28
TR199801551T2 (xx) 1998-11-23
DE19606355A1 (de) 1997-08-14
WO1997028826A3 (de) 1997-10-16
BG102682A (en) 1999-03-31
CZ253298A3 (cs) 1999-01-13
NO983672D0 (no) 1998-08-11
PL328333A1 (en) 1999-01-18
EE9800239A (et) 1998-12-15
NO983672L (no) 1998-10-09
EP0880364A2 (de) 1998-12-02
JP2000506515A (ja) 2000-05-30
IL125481A0 (en) 1999-03-12
CN1211193A (zh) 1999-03-17
WO1997028826A2 (de) 1997-08-14
IS4802A (is) 1998-07-21
EA199800714A1 (ru) 1999-02-25
BR9707416A (pt) 1999-05-25
SK107098A3 (en) 1999-01-11
AU2379297A (en) 1997-08-28
AP9801306A0 (en) 1998-09-30
KR19990082434A (ko) 1999-11-25

Similar Documents

Publication Publication Date Title
US10532025B2 (en) Intrauterine delivery system for contraception
Sivin et al. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD
Haspels Emergency contraception: a review
Grou et al. The morning-after pill—how long after?
CA2245920A1 (en) Contraceptive release systems with antibacterial and/or antiviral effect
Roumen Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing
Rowlands New technologies in contraception
AU5651100A (en) Contraceptive release system
Jensen The future of contraception: innovations in contraceptive agents: tomorrow's hormonal contraceptive agents and their clinical implications
Sitruk-Ware Vaginal delivery of contraceptives
Wildemeersch et al. Contraception with a novel ‘frameless’ intrauterine levonorgestrel-releasing drug delivery system: a pilot study
HU221162B1 (en) Use of antiprogestin for preparing pharmaceutical compositions preventing or inhibiting the fertilization
Glasier New developments in contraceptive drugs for use by women
Goldstuck et al. The new levonorgestrel-releasing intrauterine systems (Jaydess and Kyleena)
Contraceptives Progestogen-Only Contraception
Naz et al. Female contraception: Present and future perspectives
Affandi Pregnancy after removal of Etonogestrel implant contraceptive (Implanon®)
Sah et al. Current status of contraceptives use
Creatsas Prevention of adolescent pregnancies
Walthall et al. New and Developing Methods of Contraception
Maitra Newer contraceptives
Cu et al. Subject index Volume 64 July–December 2001
Danielsson Legal abortion
Okpani et al. Promoting Sexual and Reproductive Health in Africa: The Role of Family Planning
Loop et al. Subject Index Volume 52 July-December 1995

Legal Events

Date Code Title Description
FZDE Discontinued